Skip to main content

Filters

Evidence

Handbooks/Manuals

News

What are the benefits and risks of pulmonary rehabilitation (exercise training with or without additional measures) for people who have been in hospital with a sudden worsening of chronic obstructive pulmonary disease (COPD)?

Key messages

  • Pulmonary rehabilitation (exercise training with or without additional measures) improves well-being and the ability to exercise for people with COPD after they have had a sudden worsening of symptoms (an exacerbation).

  • Pulmonary rehabilitation appears to be safe after an exacerbation, but its effects on hospital readmissions and death are less clear.

  • Future studies should explore which types of programmes work best and how they should be organised.

What is an exacerbation of COPD?

People with COPD often have ongoing symptoms such as breathlessness, cough, phlegm and tiredness as part of their usual condition. An exacerbation is when these symptoms suddenly become worse than usual. During a serious exacerbation, people may become much more breathless, cough more, produce more phlegm, feel very tired or weak, or need extra medicines, oxygen or hospital care. These episodes can be frightening for people with COPD and for their families or carers. After an exacerbation, people may have poorer well-being, reduced ability to exercise and a higher risk of another hospital admission.

What is pulmonary rehabilitation?

Pulmonary rehabilitation is a structured programme designed to help people with lung disease improve their health and daily life. It usually includes exercise training and may also include education, support for self-management, and advice about managing symptoms. After a serious COPD exacerbation, pulmonary rehabilitation aims to help people recover their strength, improve their ability to exercise, manage breathlessness and reduce the risk of further health problems.

What did we want to find out?

We wanted to find out whether pulmonary rehabilitation, compared with usual care, helps people with COPD after they have had an exacerbation.

We wanted to know whether pulmonary rehabilitation improves:

  • hospital readmissions;

  • deaths from any cause;

  • well-being; and

  • the ability to exercise.

What did we do?

We searched for studies that compared pulmonary rehabilitation with usual care for people with COPD after an exacerbation. We compared and summarised the results of the studies and rated our confidence in the evidence, based on factors such as study methods and sizes.

What did we find?

We found 40 studies involving 2825 people with COPD.

In some studies, rehabilitation started while people were still in hospital. In other studies, it started after people had gone home. The rehabilitation programmes varied widely. They differed in:

  • the number of sessions completed;

  • the type and intensity of exercise training;

  • whether they included patient education or self-management support; and

  • how they were organised, for example, in a single place or across the hospital, outpatient department and the person's home.

Main results

Pulmonary rehabilitation after an exacerbation probably reduces hospital readmissions compared with usual care. It may slightly reduce deaths from any cause, although the studies' results were uncertain. Pulmonary rehabilitation also leads to large improvements in well-being and the ability to exercise. These improvements were large enough for people to notice as an important change. Pulmonary rehabilitation appeared to be safe for people with COPD after an exacerbation.

The different results across studies may be related to differences in the length and content of rehabilitation programmes and in how they were organised within healthcare systems. For example, effects may differ depending on whether programmes are delivered in a rehabilitation centre only or as part of ongoing care from hospital to home and outpatient care. Future studies should explore these possible reasons for the different findings.

What are the limitations of the evidence?

We are confident that pulmonary rehabilitation improves well-being and the ability to exercise after a COPD exacerbation.

We are less confident about the effects on hospital readmissions and death. This is because the results differed across studies. The reasons for these differences are not fully clear, but they may relate to how rehabilitation programmes were delivered, how long they lasted or how the programmes were organised within different healthcare systems.

How up to date is the evidence?

The evidence is up to date to 2 June 2026.

Background

Guidelines have provided positive recommendations for pulmonary rehabilitation after exacerbations of chronic obstructive pulmonary disease (COPD), but recent studies indicate that postexacerbation rehabilitation may not always be effective in patients with unstable COPD.

Objectives

To assess the effects of pulmonary rehabilitation after COPD exacerbations on hospital admissions (critical outcome) and other important and patient-centred outcomes (mortality, health-related quality of life (HRQL) and exercise capacity).

Search strategy

We identified studies through searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE ALL, Embase, ClinicalTrials.gov and the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP). Searches were current to 2 June 2026.

Selection criteria

Randomised controlled trials (RCTs) comparing pulmonary rehabilitation of any duration after exacerbation of COPD versus conventional care. Pulmonary rehabilitation programmes had to include at least physical exercise (endurance or strength exercise, or both). We did not apply a criterion for the minimum number of exercise sessions a rehabilitation programme had to offer to be included in the review. Control groups received conventional community care without rehabilitation.

Data collection and analysis

We expected substantial heterogeneity across trials in terms of how extensive rehabilitation programmes were (i.e. in terms of number of completed exercise sessions; type, intensity and supervision of exercise training; and patient education), duration of follow-up (< 3 months vs ≥ 3 months) and risk of bias (generation of random sequence, concealment of random allocation and blinding); therefore, we performed subgroup analyses that were defined before we carried them out. We used standard methods expected by Cochrane in preparing this update, and we used GRADE for assessing the quality of evidence.

Main results

For this update, we added 11 studies and included a total of 20 studies (1477 participants). Rehabilitation programmes showed great diversity in terms of exercise training (number of completed exercise sessions; type, intensity and supervision), patient education (from none to extensive self-management programmes) and how they were organised (within one setting, e.g. pulmonary rehabilitation, to across several settings, e.g. hospital, outpatient centre and home). In eight studies, participants completed extensive pulmonary rehabilitation, and in 12 studies, participants completed pulmonary rehabilitation ranging from not extensive to moderately extensive.

Eight studies involving 810 participants contributed data on hospital readmissions. Moderate-quality evidence indicates that pulmonary rehabilitation reduced hospital readmissions (pooled odds ratio (OR) 0.44, 95% confidence interval (CI) 0.21 to 0.91), but results were heterogenous (I2 = 77%). Extensiveness of rehabilitation programmes and risk of bias may offer an explanation for the heterogeneity, but subgroup analyses were not statistically significant (P values for subgroup effects were between 0.07 and 0.11). Six studies including 670 participants contributed data on mortality. The quality of evidence was low, and the meta-analysis did not show a statistically significant effect of rehabilitation on mortality (pooled OR 0.68, 95% CI 0.28 to 1.67). Again, results were heterogenous (I2 = 59%). Subgroup analyses showed statistically significant differences in subgroup effects between trials with more and less extensive rehabilitation programmes and between trials at low and high risk for bias, indicating possible explanations for the heterogeneity. Hospital readmissions and mortality studies newly included in this update showed, on average, significantly smaller effects of rehabilitation than were seen in earlier studies.

High-quality evidence suggests that pulmonary rehabilitation after an exacerbation improves health-related quality of life. The eight studies that used St George's Respiratory Questionnaire (SGRQ) reported a statistically significant effect on SGRQ total score, which was above the minimal important difference (MID) of four points (mean difference (MD) -7.80, 95% CI -12.12 to -3.47; I2 = 64%). Investigators also noted statistically significant and important effects (greater than MID) for the impact and activities domains of the SGRQ. Effects were not statistically significant for the SGRQ symptoms domain. Again, all of these analyses showed heterogeneity, but most studies showed positive effects of pulmonary rehabilitation, some studies showed large effects and others smaller but statistically significant effects. Trials at high risk of bias because of lack of concealment of random allocation showed statistically significantly larger effects on the SGRQ than trials at low risk of bias. High-quality evidence shows that six-minute walk distance (6MWD) improved, on average, by 62 meters (95% CI 38 to 86; I2 = 87%). Heterogeneity was driven particularly by differences between studies showing very large effects and studies showing smaller but statistically significant effects. For both health-related quality of life and exercise capacity, studies newly included in this update showed, on average, smaller effects of rehabilitation than were seen in earlier studies, but the overall results of this review have not changed to an important extent compared with results reported in the earlier version of this review.

Five studies involving 278 participants explicitly recorded adverse events, four studies reported no adverse events during rehabilitation programmes and one study reported one serious event.

Authors' conclusions

Moderate-certainty evidence indicates that pulmonary rehabilitation likely reduces hospital readmissions, while evidence for mortality is of low certainty. However, some recent studies showed no benefit of rehabilitation on hospital readmissions and mortality. Such heterogeneity of effects on hospital readmissions and mortality may be explained to some extent by the extensiveness of rehabilitation programmes and by the methodological quality of the included studies. High-certainty evidence shows moderate to large effects of pulmonary rehabilitation on HRQL and exercise capacity in people with COPD after an exacerbation.

While additional RCTs comparing rehabilitation to no rehabilitation seem questionable scientifically and ethically, future research must investigate how rehabilitation programmes can be designed and implemented to be feasible, cost-effective and attractive and accessible for patients and healthcare providers in the long term. Research must also investigate how the organisation of such programmes within specific healthcare systems determines their effects after COPD exacerbations on hospital readmissions and mortality.

Funding

This Cochrane review had no dedicated funding.

Registration

Protocol (2005) DOI: 10.1002/14651858.CD005305
Original review (2009) DOI: 10.1002/14651858.CD005305.pub2
Review update (2011) DOI: 10.1002/14651858.CD005305.pub3
Review update (2016) DOI: 10.1002/14651858.CD005305.pub4

Citation
Weber M, Gimeno-Santos E, Wuyts M, Herrero-Cortina B, Troosters T, Puhan MA. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2026, Issue 11. Art. No.: CD005305. DOI: 10.1002/14651858.CD005305.pub5.

Our use of cookies

We use necessary cookies to make our site work. We'd also like to set optional analytics cookies to help us improve it. We won't set optional cookies unless you enable them. Using this tool will set a cookie on your device to remember your preferences. You can always change your cookie preferences at any time by clicking on the 'Cookies settings' link in the footer of every page.
For more detailed information about the cookies we use, see our Cookies page.

Accept all
Configure